FDA approves first oral GLP-1 treatment for type 2 diabetes - FDA Press Releases

FDA approves Rybelsus (semaglutide) oral tablets to improve blood sugar in adults with type 2 diabetes, with diet and exercise. It is first GLP-1 receptor protein treatment approved in U.S.

from FDA Press Releases RSS Feed https://ift.tt/2OdzRyk
via IFTTT